U.S. and South Africa suspended Johnson & Johnson’s COVID-19 vaccine

U.S. and South Africa suspended Johnson & Johnson’s COVID-19 vaccine.  The U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration issued a joint statement on the 13th, stating that in view of the fact that the United States has reported 6 rare cases of severe thrombosis due to vaccinations with Johnson & Johnson’s COVID-19 vaccine, It is recommended to suspend vaccination against Johnson & Johnson’s COVID-19 vaccine.

The statement said that the relevant agencies will evaluate and investigate these 6 cases of thrombosis due to vaccination of Johnson & Johnson, and it is recommended that the vaccination of Johnson & Johnson be suspended until the results of the investigation and evaluation are available.

The statement said that the six cases were women aged 18 to 48 years old, who developed cerebral venous sinus thrombosis and thrombocytopenia 6 to 13 days after receiving the Johnson & Johnson vaccine. This side effect is “extremely rare” and its treatment is different from common blood clots.

According to data from the US Centers for Disease Control and Prevention, as of the 12th, the United States has received more than 6.8 million doses of Johnson & Johnson vaccine.

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said at a White House press conference on the 13th that the suspension of the Johnson & Johnson vaccine is out of cautious consideration and can allow relevant institutions to further understand the status of patients with adverse reactions and the mechanism of side effects. Wait. He said that the probability of such side effects is extremely low, so those who have been vaccinated by Johnson & Johnson do not need to be anxious, but they should pay attention to whether they have severe headache, shortness of breath, abdominal pain, leg pain and other symptoms within 3 weeks of vaccination. Seek medical attention.

The White House Coordinator for the Coordinator of the COVID-19 Epidemic, Jeff Zinc, said that the suspension of Johnson & Johnson’s vaccination will not have a “significant impact” on the vaccination schedule in the United States. At present, the United States has sufficient doses of Pfizer vaccine and Moderna vaccine to meet the vaccination needs.

South African Health Minister Zweli Mukez said on the 13th that in view of the United States has advised the public to suspend the Johnson & Johnson vaccine, South Africa will suspend the Johnson & Johnson vaccine, “until the causal relationship between thrombosis and Johnson & Johnson vaccine is fully investigated.” He said that nearly 300,000 medical staff in South Africa have received the Johnson & Johnson vaccine, but there have been no reports of thrombosis.

Johnson & Johnson’s COVID-19 vaccine was developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. It was approved by the US Food and Drug Administration for emergency use in the United States on February 27 this year. It is a COVID-19 vaccine that only requires one dose.

Another news:

On April 13, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued a statement, recommending that the use of Johnson & Johnson’s COVID-19 vaccine be suspended due to thrombotic symptoms. CNN reported that all federal health agencies in the United States will immediately suspend the use of the vaccine.

The report quoted a White House official as saying that this statement means that all federal health agencies, including large-scale COVID-19 vaccination sites, community health centers, and other federal health agencies, will immediately suspend vaccinations against Johnson & Johnson. Although the recommendation is also applicable to all states in the United States, given that each state has received a separate supply of vaccines, whether to suspend vaccination will be decided by each locality.

The reason why the Johnson & Johnson vaccine is recommended to be discontinued is that some vaccinators have experienced side effects that are not included in the emergency use license of the vaccine. At present, 6 people in the United States have reported “rare and serious thrombosis.” White House officials emphasized that this side effect is extremely rare, and it is hoped that medical institutions will have time to learn about various side effects and find the best treatment.

(source:internet, reference only)

Disclaimer of medicaltrend.org